A Case of Advanced Thymic Carcinoma in Which Carboplatin and Nab-paclitaxel Were Significantly Effective After Progression on Lenvatinib-Reference-Cited by-同舟云学术

A Case of Advanced Thymic Carcinoma in Which Carboplatin and Nab-paclitaxel Were Significantly Effective After Progression on Lenvatinib

Published:2022-04-20 Issue:2 Volume:62 Page:115-120
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Mizuta Remi¹,Fukuda Minoru¹,Suyama Takayuki¹,Gyotoku Hiroshi¹,Takemoto Shinnosuke¹,Yamaguchi Hiroyuki¹,Sawai Toyomitsu²,Irie Junji³,Ashizawa Kazuto⁴,Mukae Hiroshi¹

Affiliation:

1. Department of Respiratory Medicine, Nagasaki University Hospital

2. Department of Respiratory Medicine, Nagasaki Harbor Medical Center

3. Department of Pathology, Nagasaki Harbor Medical Center

4. Department of Clinical Oncology, Nagasaki University Graduate School of Biomedical Sciences

Publisher

Japan Lung Cancer Society

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.jstage.jst.go.jp/article/haigan/62/2/62_115/_pdf

Reference13 articles.

1. 1. Shimosato Y, Kameya T, Nagai K, Suemasu K. Squamous cell carcinoma of the thymus: an analysis of eight cases. Am J Surg Pathol. 1977; 1: 109-121.

2. 2. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO histological classification of tumors of the thymus. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2015: 183.

3. 3. 日本肺癌学会, 編集. 肺癌診療ガイドライン2020年版～悪性胸膜中皮腫・胸腺腫瘍含む. 金原出版; 2020.

4. 4. Sato J, Satouchi M, Itoh S, Okuma Y, Niho S, Mizugaki H, et al. Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicenter, phase 2 trial. Lancet Oncol. 2020; 21: 843-850.

5. 5. Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011; 29: 2060-2065.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lenvatinib;Reactions Weekly;2023-04-01